Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study.
Miyake M, Nishimura N, Iemura Y, Yoshikawa M, Torimoto K, Tomioka A, Sakamoto K, Matsumura Y, Naoi M, Ichii D, Inoue K, Narita K, Oyama N, Tomizawa M, Shimizu T, Ohnishi K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Tanaka N, Fujimoto K; Nara Urological Research and Treatment Group.
Miyake M, et al. Among authors: torimoto k.
Clin Genitourin Cancer. 2025 Jun;23(3):102326. doi: 10.1016/j.clgc.2025.102326. Epub 2025 Mar 8.
Clin Genitourin Cancer. 2025.
PMID: 40175211